Skip to main navigation Skip to search Skip to main content

Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients

  • Fatih M. Uckun
  • , Hong Ma
  • , Rita Ishkhanian
  • , Martha Arellano
  • , Anoush Shahidzadeh
  • , Amanda Termuhlen
  • , Paul S. Gaynon
  • , Sanjive Qazi

Research output: Contribution to journalArticlepeer-review

Abstract

We examined the constitutive function of the Ikaros (IK) transcription factor in blast cells from pediatric B-precursor acute lymphoblastic leukemia (BPL) patients using multiple assay platforms and bioinformatics tools. We found no evidence of diminished IK expression or function for primary cells from high-risk BPL patients including a Philadelphia chromosome (Ph)+ subset. Relapse clones as well as very aggressive in vivo clonogenic leukemic B-cell precursors isolated from spleens of xenografted NOD/SCID mice that developed overt leukemia after inoculation with primary leukemic cells of patients with BPL invariably and abundantly expressed intact IK protein. These results demonstrate that a lost or diminished IK function is not a characteristic feature of leukemic cells in Ph+ or Ph- high-risk BPL.

Original languageEnglish (US)
Article numbere80732
JournalPloS one
Volume8
Issue number11
DOIs
StatePublished - Nov 20 2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients'. Together they form a unique fingerprint.

Cite this